CI vs IBO · P/E 2.4, rev $274.90B vs rev $18.0K
Cigna Corp (CI) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. IBO currently screens at market cap $7.6M.
Not investment advice. Open the CI and IBO stock pages for the full models.
Not investment advice.